Syngenta (SYT), Lattice Semiconductor (LSCC) Weaken as China's SAFE Said to Pause Deals
- Donald Trump Sworn in as 45th U.S. President
- Wall Street ends higher as Trump becomes president
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Apple (AAPL) Sues Qualcomm (QCOM) Over Patent Royalties in Antitrust Case - Bloomberg
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
Weakness in Syngenta (NYSE: SYT), Ingram Micro (NYSE: IM), and Lattice Semiconductor (NASDAQ: LSCC) Tuesday was tied to reports that China's SAFE has begun putting its approval of pending outbound investment on hold, if they have remaining capital outflow of $50 million or above, according to a report from Bloomberg. These deals will be approved by SAFE after they pass additional reviews by several other government agencies,.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Syngenta (SYT)/Chemchina Said to Move Closer to EU Approval - Bloomberg, Citing Mlex
- Bristol-Myers Squibb (BMY), Ono Enter Settlement and License Agreement with Merck (MRK) to Resolve PD-1 Antibody Patent Litigation
- Mallinckrodt (MNK) Set to be Charged for Using Monopoly to Jack Up Price - NYP
Create E-mail Alert Related CategoriesLitigation, Mergers and Acquisitions, Rumors
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!